QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director
Business Wire•06/11/2026•10:00 ET
0
Key Highlights
- ➤Shareholders overwhelmingly approve Jonathan M. Pratt as QIAGEN managing director
- ➤Jon Pratt joins QIAGEN’s Managing Board as CEO on September 1, 2026
- ➤Roland Sackers remains QIAGEN’s Managing Board CFO
- ➤Shareholders approve Thierry Bernard’s discharge through September 1, 2026
QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that shareholders overwhelmingly approved the appointment of Jonathan M. Pratt as a Managing Director and member of the QIAGEN Managing Board at an Extraordinary General Meeting of Shareholders.
Get started
Create a free account to read the full story.